References
- Ishikawa I, Nakashima K, Koseki T et al, Induction of the immune response to periodontopathic bacteria and its role in the pathogenesis of periodontitis. Periodontol 2000, 1997;14:79-111 https://doi.org/10.1111/j.1600-0757.1997.tb00193.x
- Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med 2001;79:243-53 https://doi.org/10.1007/s001090100226
- Yasuda H, Shima N, Nakagawa N et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis- inhibitory factor and is identical to TRANCE/ RANKL. Proc Natl Acad Sci U S A. 1998;95: 3597-602 https://doi.org/10.1073/pnas.95.7.3597
- Quinn JMW, Horwood NJ, Elliott J, Gillespie MT, Martin TJ. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation, J Bone Miner Res 2000;15(8): 1459-66 https://doi.org/10.1359/jbmr.2000.15.8.1459
- Taubman MA, Kawai T, Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit Rev Oral Biol Med 2001;12:125-35 https://doi.org/10.1177/10454411010120020301
- Kanamaru F, Iwai H, Ikeda T, Nakajima A, Ishikawa I, Azuma, Expression of membrane- bound and soluble receptor activator of NF-kappaB ligand (RANKL) in human T cells. Immunol Lett 2004;94:239-46 https://doi.org/10.1016/j.imlet.2004.05.010
- Katagiri T, Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 2002;8:147-59 https://doi.org/10.1034/j.1601-0825.2002.01829.x
- Wada T, Nakashima T, Hiroshi N, Penninger JM. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 2006;12:17-25 https://doi.org/10.1016/j.molmed.2005.11.007
- Hofbauer LC, Khosla S, Dunstan CR et al. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000;15:2-12 https://doi.org/10.1359/jbmr.2000.15.1.2
- Hsu H, Lacey DL, Dunstan CR et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A 1999;96:3540-5 https://doi.org/10.1073/pnas.96.7.3540
- Yasuda H, Shima N, Nakagawa N et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998;139:1329-37 https://doi.org/10.1210/en.139.3.1329
- Hormdee D, Nagasawa T, Kiji M. Protein kinase-A-dependent osteoprotegerin production on interleukin-1 stimulation in human gingival fibroblasts is distinct from periodontal ligament fibroblasts. Clin Exp Immunol 2005;142:490-7
- Mizuno N, Shiba H, Mouri Y et al. Characterization of epithelial cells derived from periodontal ligament by gene expression patterns of bone-related and enamel proteins. Cell Biol Int 2005;29:111-7 https://doi.org/10.1016/j.cellbi.2004.11.012
- Nagasawa T, Kiji M, Yashiro R et al. Roles of receptor activator of nuclear factor- kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease. Periodontol 2000. 2007;43:65-84. Review https://doi.org/10.1111/j.1600-0757.2006.00185.x
- Sakata M, Shiba H, Komatsuzawa H et al. Expression of osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human dental mesenchymal cells and epithelial cells. J Bone Miner Res 1999;14:1486-92 https://doi.org/10.1359/jbmr.1999.14.9.1486
- Teng YT, Nguyen H, Gao X et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 2000;106:R59-67 https://doi.org/10.1172/JCI10763
- Ogasawara T, Yoshimine Y, Kiyoshima T et al. In situ expression of RANKL, RANK, osteoprotegerin and cytokines in osteoclasts of rat periodontal tissue. J Periodontal Res 2004;39:42-9 https://doi.org/10.1111/j.1600-0765.2004.00699.x
- Muhlemann HR and Son S. Gingival sulcus bleeding a leading symptom in initial gingivitis. Helv Odontol Acta 1971;15:107
- Amitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6 https://doi.org/10.1902/annals.1999.4.1.1
- Kang MG, Cha HG, Song SH et al. MMP-2, MMP-8 Expression in gingival tissue of chronic periodontitis associated to Type 2 Diabetes Mellitus. Journal of Korean Academy of Periodontology 2005;35:661-674
- Cho JY, Xing S, Liu X et al. Expression and activity of human Na+/I-symporterinhumangliomacellsbyadenovirus- mediatedg enedelivary. GeneTherapy 2000;7:740-749
- Choi BK, Moon SY, Cha JH, Kim KW, Yoo YJ. Prostaglandin E2 is a main mediator in receptor activator of nuclear factor-kB ligand- dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii. J Periodontol 2005;76:813-820 https://doi.org/10.1902/jop.2005.76.5.813
- Bickel M, Axtelius B, Solioz C, Attstrom R. Cytokine gene expression in chronic periodontitis. J Clin Periodontol 2001;28(9): 840-7 https://doi.org/10.1034/j.1600-051x.2001.028009840.x
- Ishihara Y, Nishihara T, Kuroyanagi T et al. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodontal Res 1990;32:524-9 https://doi.org/10.1111/j.1600-0765.1997.tb00568.x
- Crotti T, Smith MD, Hirsch R et al. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodontal Res 2003;38:380-7 https://doi.org/10.1034/j.1600-0765.2003.00615.x
- Theoleyre S, Wittrant Y, Tat SK et al. The molecular triad OPG/RANK/RANKL: in volvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev 2004;15:457-75 https://doi.org/10.1016/j.cytogfr.2004.06.004
- Nagasawa T, Kobayashi H, Kiji M et al. LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. Clin Exp Immunol 2002; 130:338-44 https://doi.org/10.1046/j.1365-2249.2002.01990.x
- Liu D, Xu JK, Figliomeni L et al. Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. Int J Mol Med 2003;11: 17-21
- Mogi M, Otogoto J, Ota N, Togari A. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res 2004;83:166-9 https://doi.org/10.1177/154405910408300216
- Bostanci N, Ilgenli T, Emingil G et al. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J Clin Periodontol 2007;34:370-6 https://doi.org/10.1111/j.1600-051X.2007.01061.x
- Bostanci N, Ilgenli T, Emingil G et al. Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases. J Periodontal Res 2007;42:287-93 https://doi.org/10.1111/j.1600-0765.2006.00946.x
- Okahashi N, Inaba H, Nakagawa I et al. Porphyromonas gingivalis induces receptor activator of NF-kappaB ligand expression in osteoblasts through the activator protein 1 pathway. Infect Immun 2004;72:1706-14 https://doi.org/10.1128/IAI.72.3.1706-1714.2004
- Belibasakis GN, Johansson A, Wang Y et al. Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin. Cytokine 2005;30:56-63 https://doi.org/10.1016/j.cyto.2004.11.008
- Kikuchi T, Matsuguchi T, Tsuboi N et al. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J Immunol 2001;166:3574-9 https://doi.org/10.4049/jimmunol.166.5.3574
- Kawai T, Matsuyama T, Hosokawa Y et al. Band T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol 2006; 169:987-98 https://doi.org/10.2353/ajpath.2006.060180
- Huang JC, Sakata T, Pfleger LL et al. PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res 2004; 19:235-44 https://doi.org/10.1359/JBMR.0301226
- Tsukii K, Shima N, Mochizuki S et al. Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha, 25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. Biochem Biophys Res Commun. 1998;246:337-41 https://doi.org/10.1006/bbrc.1998.8610